Focused On LifeDeveloping novel therapies for serious diseases
Driven By ScienceRapid, efficient, cost-effective approach
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families.
Medivation is proud to be a 2013 Top WorkplaceLearn More
December 4, 2013 Medivation and Astellas Initiate Phase 2 Study of Enzalutamide in Advanced Breast Cancer That Is Estrogen or Progesterone Receptor Positive and HER2 Normal Learn More